400 related articles for article (PubMed ID: 15162290)
1. Follicular conjunctivitis caused by a mantle cell lymphoma.
Amstutz CA; Michel S; Thiel MA
Klin Monbl Augenheilkd; 2004 May; 221(5):398-400. PubMed ID: 15162290
[TBL] [Abstract][Full Text] [Related]
2. Bilateral conjunctival MALT lymphoma mimicking chronic conjunctivitis.
Seker M; Ozdemir B; Bilici A; Ustaalioğlu BB; Sonmez B; Yilmaz BE; Kurnaz E; Gumus M; Yaylaci M
Onkologie; 2010; 33(6):317-20. PubMed ID: 20523096
[TBL] [Abstract][Full Text] [Related]
3. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
Yoo SB; Kim YA; Jeon YK; Kim CW
Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
[TBL] [Abstract][Full Text] [Related]
4. Lethal Epstein-Barr virus associated NK/T-cell lymphoma with primary manifestation in the conjunctiva.
Widmer S; Tinguely M; Egli F; Thiel MA
Klin Monbl Augenheilkd; 2005 Mar; 222(3):255-7. PubMed ID: 15785994
[TBL] [Abstract][Full Text] [Related]
5. [Mantle cell lymphoma mimicking chronic lymphocytic leukemia].
Hanamura A; Hayakawa M; Naito K
Rinsho Ketsueki; 2005 Jan; 46(1):13-8. PubMed ID: 16708912
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival lymphoma masquerading as chronic conjunctivitis.
Akpek EK; Polcharoen W; Ferry JA; Foster CS
Ophthalmology; 1999 Apr; 106(4):757-60. PubMed ID: 10201599
[TBL] [Abstract][Full Text] [Related]
7. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
Romaguera JE; Fayad L; Rodriguez MA; Broglio KR; Hagemeister FB; Pro B; McLaughlin P; Younes A; Samaniego F; Goy A; Sarris AH; Dang NH; Wang M; Beasley V; Medeiros LJ; Katz RL; Gagneja H; Samuels BI; Smith TL; Cabanillas FF
J Clin Oncol; 2005 Oct; 23(28):7013-23. PubMed ID: 16145068
[TBL] [Abstract][Full Text] [Related]
8. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
Wang M; Fayad L; Cabanillas F; Hagemeister F; McLaughlin P; Rodriguez MA; Kwak LW; Zhou Y; Kantarjian H; Romaguera J
Cancer; 2008 Nov; 113(10):2734-41. PubMed ID: 18973182
[TBL] [Abstract][Full Text] [Related]
9. [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].
Coupland SE
Ophthalmologe; 2004 Feb; 101(2):197-215; quiz 216-7. PubMed ID: 15046030
[TBL] [Abstract][Full Text] [Related]
10. Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
Inamdar KV; Romaguera JE; Drakos E; Knoblock RJ; Garcia M; Leventaki V; Medeiros LJ; Rassidakis GZ
Cancer; 2009 Oct; 115(20):4727-36. PubMed ID: 19708031
[TBL] [Abstract][Full Text] [Related]
11. Mantle cell lymphoma diagnosed by conjunctival salmon-pink lesion biopsy.
Matsuo T; Ichimura K; Kubonishi S
J Clin Exp Hematop; 2014; 54(2):143-7. PubMed ID: 25318947
[TBL] [Abstract][Full Text] [Related]
12. Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine.
Garcia M; Romaguera JE; Inamdar KV; Rassidakis GZ; Medeiros LJ
Cancer; 2009 Mar; 115(5):1041-8. PubMed ID: 19170236
[TBL] [Abstract][Full Text] [Related]
13. [Recent progress in the therapeutic strategy for follicular lymphoma and mantle cell lymphoma].
Ogura M
Rinsho Ketsueki; 2006 Jun; 47(6):495-512. PubMed ID: 16862978
[No Abstract] [Full Text] [Related]
14. Mantle cell lymphoma in the ocular adnexal region.
Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
[TBL] [Abstract][Full Text] [Related]
15. The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma.
Ritchie DS; Seymour JF; Grigg AP; Roberts AW; Hoyt R; Thompson S; Szer J; Prince HM
Ann Hematol; 2007 Feb; 86(2):101-5. PubMed ID: 17089127
[TBL] [Abstract][Full Text] [Related]
16. [An adult case of precursor B cell lymphoblastic lymphoma extending from right neck to upper cervical spinal region].
Nishihara M; Kudo H; Mizuno I; Taomoto K; Kohmura E
No Shinkei Geka; 2005 Nov; 33(11):1107-11. PubMed ID: 16277225
[TBL] [Abstract][Full Text] [Related]
17. Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract.
Michopoulos S; Petraki K; Matsouka C; Kastritis E; Chrysanthopoulou H; Dimopoulos MA
J Clin Oncol; 2008 Mar; 26(9):1555-7. PubMed ID: 18349408
[No Abstract] [Full Text] [Related]
18. [Duodenal polyposis disclosing mantle-cell lymphoma].
Moulin O; Boucher E; Samson T; Coutant G; Helie C; Algayres JP
Gastroenterol Clin Biol; 2002 Nov; 26(11):1055. PubMed ID: 12483144
[No Abstract] [Full Text] [Related]
19. [Mantle cell lymphoma markedly infiltrated into adrenal glands with adrenal insufficiency].
Hashimoto R; Iwakiri R; Tsutsumi H; Ohta M; Mori M
Rinsho Ketsueki; 2004 Jul; 45(7):551-6. PubMed ID: 15359915
[TBL] [Abstract][Full Text] [Related]
20. Primary conjunctival follicular lymphoma mimicking chronic conjunctivitis.
Labrador Velandia S; García Lagarto E; Saornil MA; García Álvarez C; Cuello R; Diezhandino P
Arch Soc Esp Oftalmol; 2016 Feb; 91(2):86-9. PubMed ID: 26560164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
